MazenElkurdDO(He/Him)

Movement Disorder

Neurologist | Director, BUMC Movement Disorders Center - Baylor Scott & White Health

Dr. Elkurd is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Elkurd is a board-certified neurologist with additional fellowship training in movement disorders. Dr. Elkurd specializes in movement disorders, and is director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health. He has strong interests in Parkinson disease, tremors, dystonia, and other movement disorders. Dr. Elkurd has published numerous peer-reviewed papers in the area of movement disorders, is involved in education of medical students and residents and is involved in numerous professional organizations locally, nationally and internationally.

University of Texas Southwestern Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2019 - 2020
MedStar Health/Georgetown University HospitalResidency, Neurology, 2016 - 2019
MedStar Health (Baltimore)Internship, Internal Medicine, 2015 - 2016
A.T. Still University, School of Osteopathic Medicine in ArizonaClass of 2015
The University of Texas at ArlingtonB.S., Major in Biology, minor in Chemistry, Magna Cum Laude, 2007 - 2010

PubMed

11 citations
Improving tremor response to focused ultrasound thalamotomy.
James M Holcomb, Rajiv Chopra, Fabricio S Feltrin, Mazen Elkurd, Rasheda El-Nazer
Brain Communications. 2023-01-01
19 citations
Focused ultrasound using a novel targeting method four-tract tractography for magnetic resonance-guided high-intensity focused ultrasound targeting.
Fabricio S Feltrin, Rajiv Chopra, Nader Pouratian, Mazen Elkurd, Rasheda El-Nazer
Brain Communications. 2022-01-01
13 citations
The role of extended-release amantadine for the treatment of dyskinesia in Parkinson's disease patients.
Mazen T. Elkurd, Laxman Bahroo, Rajesh Pahwa
Neurodegenerative Disease Management. 2018-03-22

Journal Articles

Keeping up with the clinical advances: tardive dyskinesia
Mazen Elkurd, Laxman Bahroo, CNS Spectrums, 8/2019
The role of extended-release amantadine for the treatment of dyskinesia in Parkinson’s disease patients
Elkurd T Mazen, Laxman B Bahroo & Rajesh Pahwa, Neurodegerative Disease Management, 3/22/2018
Hyperkinetic Movement Disorders
Bahroo, L., Elkurd M., and Pagan, F., Practical Neurology, 1/1/2018
Anti-Alpha Synuclein Therapies in Parkinson's Disease
Elkurd, M., Torres-Yaghi, Y., Bahroo, L., Moussa, C. and Pagan, F., Practical Neurology, 1/1/2018
Effect of Educational Intervention on Type 2 Diabetes Mellitus Control
Elkurd M, Wadud M, Nakata J, Voelkel B and J Lewis, Open Journal of Preventative Medicine, 2014
Effect of Educational Intervention on Type II Diabetes Mellitus Control
Elkurd, M., Nakata, J., Voelkel, B., Wadud, M. and Lewis, J.H., Open Journal of Preventive Medicine, 1/1/2014
Join now to see all

Abstracts/Posters

Pseudobulbar Affect in Parkinsonian Disorders
Mazen Elkurd, Cameron Mohammadi, Yasar Torres Yagi, Fernando Pagan, American Academy of Neurology Annual Meeting, Philadelphia, PA, 5/7/2019
Relapsing demyelination over 12 years following radiation for metastatic brain lesion
Mazen Elkurd, Jessica Stevens, Nancy Hu and Carlo Tornatore, ACTRIMS Forum 2019, Dallas, TX, 3/1/2019
Frontal Lobe Epilepsy: The Great Masquerader
Mazen Elkurd, MedStar Health Research Symposium, Bethesda, MD, 5/2018
Effect of Educational Intervention on Type II Diabetes Mellitus Control
Mazen Elkurd, Jena Nakata, Burke Voelkel, Mohammad Wadud, Joy H. Lewis, National Association of Community Health Centers, Chicago, IL, 3/2013
Join now to see all